Effects of Dex-Verapamil on Doxorubicin cytotoxicity in p388 murine leukemia cells

Anti-Cancer Drug Design

Volumn 12, Issue 4, 1997, Pages 261-276

  Noviello, Elvira ^a   Allievi, Enrico ^b   Russo, Patrizia ^c   Parodi, Silvio ^c  

^a Advanced Biotechnology Center   (Italy)

^b KNOLL Pharmaceutics ^*  (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Dex Verapamil; Doxorubicin; Reversing agent

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOXORUBICIN; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG CYTOTOXICITY; DRUG SENSITIVITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL LINE; LEUKEMIA P 388; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; LEUKEMIA P388; MICE; MICE, INBRED STRAINS; SURVIVAL ANALYSIS; VERAPAMIL;

EID: 0030946832     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. AKIYAMA, S., CORNWELL, M.M., KUWANO, M , PASTAN, I & GOTTESMAN, M.M (1987). Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Molecular Pharmacology, 33, 144.
2. AL GHARABLY, N.M , OSMAN, A.M , AL SHABANAH, O.A., AL BEKAIRI, A M. & AL HARBI, M.M. (1993). Potentiation of doxorubicin cytotoxicity by the calcium channel blocher verapamil in Earlich ascites cells. Experimental Chemotherapy, 39, 410.
3. BOESCH, D , GAVERIAUX, C., JACHEZ, B., POURTIER-MANZANEDO, A., BOLLINGER, P. & LOOR, F. (1991). In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Research, 51, 4226.
4. BOIOCCHI, M. & TOFFOLI, G. (1992). Mechanisms of MDR in human tumor cell lines and complete reversion of cellular resistance. European Journal of Cancer, 28A, 1099.
5. BRUNO, N.A. & SLATE, D L. (1990). Effect of exposure to calcium entry blockers on doxorubicin accumulation and cytotoxicity in multidrug-resistant cells. Journal of the National Cancer Institute, 82, 419.
6. CAPRANICO, G , DASDIA, T. & ZUNINO, F. (1986). Comparison of doxorubicin-induced DNA damage in doxorubicin sensitive and resistant P388 murine leukemia cells. International Journal of Cancer, 37, 227.
7. CAPRANICO, G., DE ISABELLA, P., CASTELLI, C., SUPINO, R., PARMIANI, C. & ZUNINO, F (1989). P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines. British Journal of Cancer, 59, 682.
8. CURTIS, M.J. & WALKER, M J A. (1986). The mechanism of action of the optical enantiomers of verapamil against ischaemia-induced arrhythmias in the conscious rat. British Journal of Pharmacology, 89, 137.
9. DANO, K. (1972). Cross resistance between vinka alkaloids and anthracyclines in Ehrlich ascites tumor in vivo (Part 1). Cancer Chemotherapy Reports, 56, 701.
10. ECHIZEN, H , BRECHT, T., NIEDERGESASS, S , VOGELGESANG, B. & EICHELBAUM, M. (1985a). The effect of dextro-, levo- and racemic verapamil on atrioventricular conduction in humans. American Heart Journal, 109, 210.
11. ECHIZEN, H., VOGELGESANG, B & EICHELBAUM, M. (1985b). The effect of D,L-Verapamil on atrioventricular conduction in relation to its stereoselective first pass metabolism. Clinical Pharmacology and Therapeutics, 38, 71.
12. ECHIZEN, H., MANZ, M. & EICHELBAUM, M (1988). Electrophisiologic effect of dextro and levo-verapamil on sinus node and av node function in humans. Journal of Cardiovascular Pharmacology, 12, 543.
13. EICHELBAUM, M., MIKUS, G. & VOGELGESANG, B. (1984). Pharmacokinctics of (+), (-) and (±) verapamil after intravenous administration. British Journal of Clinical Pharmacology, 17, 453.
14. ENDICOTT, J.A. & LING, V (1989). The biochemistry of P-glycoprotein mediated multidrug resistance. Annual Review in Biochemistry, 58, 137.
15. GOTTESMAN, M.M. & PASTAN, I. (1988). The multidrug-transporter a double-edged sword. Journal of Biological Chemistry, 263, 12163.
16. GOTTESMAN, M.M. & PASTAN, I. (1989a). Resistance to multiple chemotherapeutic agents in human cancer cells. Trends in Pharmacological Sciences, 9, 54.
17. GOTTESMAN, M.M. & PASTAN, I (1989b). Clinical trials of agents that reverse multidrug resistance. Editorial. Journal of Clinical Oncology, 7, 409.
18. HAMADA, H. & TSURUO, T. (1986). Functional role for the 170- to 180-kDa glycoprotein specific to drug resistant tumor cells as revealed by monoclonal antibodies. Proceedings of National Academy of Science, USA, 83, 7785.
19. JAFFRÉZOU, J.P., HERBERT, J.M , LEVADE, T., GAU, M.N., CHATELAIN, P. & LAURENT, G. (1991). Reversal of multidrug resistance by calcium channel blocker SR 33557 without photoaffinity labeling of P-glycoprotein. Journal of Biological Chemistry, 266, 19858.
20. JOHNSON, R.L., CHITNESS, M.P., EMBREY, W.M. & GREGORY, E B. (1978). In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treatment Reports, 62, 1535.
21. KARTNER, N., EVERDEN-PORELLE, D , BRADDLEY, G. & LING, V. (1985). Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibody. Nature, 316, 820.
22. KAYE, S.B. (1988). The multidrug resistance phenotype. British Journal of Cancer, 58, 691.
23. KEILHAUER, G., EMLING, F., RASCHACK, M., GRIES, J. & SCHLICK, E. (1989). The use of verapamil is superior to racemic verapamil in breaking multidrug resistance of malignant cells. Proceedings of the American Association for Cancer Research, 30, 503.
24. LEONCE, S, PIERRÉ, A., ANSTETT, M., PEREZ, V., GENTON, A., BIZZARI, J.P. & ATASSI, G. (1992). Effects of a new triazinoaminopiperidine derivative on Adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Biochemical Pharmacology, 44, 1707.
25. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. Journal of Immunological Methods, 65, 55.
26. PLUMB, J.A., WISHART, G.C., SETANOIANS, A , MORRISON, J.G., HAMILTON, X, BICKNELL, S R. & KAYE, S.B. (1994). Identification of a multidrug resistance modulator with clinical potential by analysis of synergistic activity in vitro, toxicity in vivo and growth delay in a solid human tumor xenograft. Biochemical Pharmacology, 47, 257.
27. RIORDAN, J.R. & LING, V (1985) Genetic and biochemical characterization of multidrug resistance. Pharmacological Therapy, 28, 51.
28. ROGAN, A M , HAMILTON, T.C., YOUNG, R.C., KLECHER, R.W.,JR & OZOLZ, R.F. (1984). Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science, 224, 994.
29. SALMON, S.E., HAMBURGHER, A W , SOEHNLEN, B., DURIE, B.G H., ALBERTS, D.S. & MOON, TE. (1978). Quantitation of differential sensitivity of human tumor stem cells to anticancer drug. New England Journal of Medicine, 298, 1321.
30. SCHUMAKER, K , LADDA, E., BÜHL, K., WEIMER, A., ESER, C., HAMPRECHT, K., TRAUGOTT, U, ROLLER, E., SCHALK, K.P & EICHELBAUM, M (1991). R-Verapamil, a modulator of MDR: Phase I clinical trial. Journal of Cancer Research and Clinical Oncology, 117 (Suppl.), 113.
31. SCHUURHUIS, G.J , BROXTERMAN, H J., CERVANTES, A., VAN HEIJNINGEN, T.H.M., DE LANGE, J.H.M., BAAK, JPA., PINEDO, H.M. & LANKELMA, J. (1989). Quantitative determination of factors contributing to doxorubicin resistance in multidrug resistance cells. Journal of the National Cancer Institute, 81, 1887.
32. SKOVSGAARD, T. (1978). Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Research, 38, 4722.
33. SLATER, L.M., SWEET, P , STUPECKI, M & GUPTA, S (1986). Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. Journal of Clinical Investigation, 77, 1405.
34. THIEBAUT, F., TSURUO, T , HAMADA, H , GOTTESMAN, M.M., PASTAN, I. & WILLINGHAM, M.C. (1987). Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proceedings of National. Academy of Science, USA, 84, 7735.
35. TOFFOLI, G., TUMIOTTO, L., GIGANTE, M, DALL'ARCHE, M G., PERIN, T. & BOIOCCHI, M (1993). Increased chemosensitivity to doxorubicin of intrinsically multidrug-resistant human colon carcinoma cells by prolonged exposure to verapamil. European Journal of Cancer, 29A, 1776.
36. TSURUO, T. (1983). Reversal of acquired resistance to vinca alkaloids and anthracyclines antibiotics. Cancer Treatment Reports, 67, 889.
37. TSURUO, T , LIDA, H TSUKAGOSHI, S. & SAKURAI, Y (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by Verapamil. Cancer Research, 41, 1967.
38. TSURUO, T., IIDA, H., NOJIRI, M , TSUKAGOSHI, S. & SAKURAI, Y. (1983). Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Research, 43, 2905.
39. TSURUO, T., LIDA, H., KITATANI, Y., KOBOTA, K , TSUKAGOSHI, S. & SAKURAI, Y (1984). Effect of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Research, 44, 4303.
40. WILKOFF, L.J. & DULMODGE, E.A. (1978). Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs and actinomycin D. Journal of the National Cancer Institute, 61, 1521.
41. YANOVICH, S. & PRESTON, L. (1984). Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells. Cancer Research, 44, 1743.